Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease

被引：101

作者：

Thayu, M

Markowitz, JE

Mamula, P

Russo, TA

Muinos, WI

Baldassano, RN

机构：

[1] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA

[2] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA

[3] Childrens Hosp, Div Pediat Gastroenterol, Miami, FL USA

来源：

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION | 2005年 / 40卷 / 02期

关键词：

D O I：

10.1097/00005176-200502000-00026

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：220 / 222

页数：3

共 20 条

[1] Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment [J].

Aithal, GP ;

Mansfield, JC .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (08) :1101-1108

[2] The relationship between infliximab treatment and lymphoma in Crohn's disease [J].

Bickston, SJ ;

Lichtenstein, GR ;

Arseneau, KO ;

Cohen, RB ;

Cominelli, F .

GASTROENTEROLOGY, 1999, 117 (06) :1433-1437

[3] The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients [J].

Colombel, JF ;

Loftus, EV ;

Tremaine, WJ ;

Egan, LJ ;

Harmsen, WS ;

Schleck, CD ;

Zinsmeister, AR ;

Sandborn, WJ .

GASTROENTEROLOGY, 2004, 126 (01) :19-31

[4]

DAYSHARSH GA, 2002, GASTROENTEROLOGY, V122, P72

[5]

Dong Jingyu, 2003, Arch Pathol Lab Med, V127, pe119

[6]

FARCET JP, 1990, BLOOD, V75, P2213

[7] Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine [J].

Fraser, AG ;

Orchard, TR ;

Robinson, EM ;

Jewell, DP .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (07) :1225-1232

[8]

GREENSTEIN AJ, 1992, CANCER-AM CANCER SOC, V69, P1119

[9]

GREENSTEIN AJ, 1985, CANCER, V56, P2914, DOI 10.1002/1097-0142(19851215)56:12<2914::AID-CNCR2820561232>3.0.CO

[10]

2-J

← 1 2 →